Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,522 | -32,539 | -24,790 | -15,405 | -64,767 |
| Depreciation Amortization | 857 | 680 | 499 | 330 | 1,554 |
| Accounts payable and accrued liabilities | 1,880 | 1,719 | 1,653 | 716 | -556 |
| Other Working Capital | 3,996 | 1,786 | -318 | -2,267 | 4,204 |
| Other Operating Activity | 7,280 | 3,324 | 2,779 | 2,779 | 11,609 |
| Operating Cash Flow | $-31,509 | $-25,030 | $-20,177 | $-13,847 | $-47,956 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 39,046 | 39,046 | 39,046 | 39,046 | 54,980 |
| PPE Investments | 1,170 | 1,170 | 1,170 | 585 | -34 |
| Investing Cash Flow | $40,216 | $40,216 | $40,216 | $39,631 | $54,946 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 23 | 14 | 14 | N/A | 8,874 |
| Financing Cash Flow | $23 | $14 | $14 | $N/A | $8,874 |
| Beginning Cash Position | 37,573 | 37,573 | 37,573 | 37,573 | 21,709 |
| End Cash Position | 46,303 | 52,773 | 57,626 | 63,357 | 37,573 |
| Net Cash Flow | $8,730 | $15,200 | $20,053 | $25,784 | $15,864 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,509 | -25,030 | -20,177 | -13,847 | -47,956 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -34 |
| Free Cash Flow | -31,509 | -25,030 | -20,177 | -13,847 | -47,990 |